Investor Ideas #Potcasts
597, #Cannabis News and #Stocks on the Move; (CSE: $ORCD.C), (TSX: $LABS.TO),
(TSX: $XLY.TO), (TSX: $VLNS.TO) (OTCQX: $VLNCF)
Delta, Kelowna, BC, August 18, 2021 (Investorideas.com Newswire)
www.Investoride, as.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2021/081821-StocksToWatch.mp3
Read this in full
at https://www.investorideas.com/News/2021/cannabis-potcasts/08181ORCD-LABS-XLY-VLNS.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few public and private company announcements.
MediPharm
Labs Corp.
(TSX: LABS) (OTCQX: MEDIF), a pharmaceutical company that
specializes in cannabis, announced that it has received approval to
ship medical cannabis oil to Brazil. This approval, issued by both ANVISA and
Health Canada, allows initial shipments to patients for the Company’s partner
XLR8. The shipment is a crucial milestone for the Company in using its
pharmaceutical Good Manufacturing Practices (“GMP”) platform for international
manufacturing and distribution.
The Company and XLR8, a Curitiba
based value-added distributor serving Brazil, entered into an agreement in
September 2020. The two-year agreement is to commence from the time of ANVISA
Sanitary Product Authorization, which is expected later this year. The
registration will be for a mix of medical oil SKUs such as balanced and high
CBD formulas. This initially approved delivery goes directly to patients under
the compassionate care program, allowing XLR8 to begin its medical cannabis
research. This first delivery opens a regulatory pathway for future
opportunities for authorized product distribution. Brazil is one of the most
significant medical cannabis market opportunities in LATAM.
“MediPharm Labs continues to execute
our on plan to provide pharmaceutical-grade medical cannabis products to
patients around the world. It is with great partners, like XLR8, with local
country expertise that we can effectively achieve this goal,” said Keith
Strachan, President and Interim CEO, MediPharm Labs.
”Based on our business pillars,
clinical research development is a strategic path to provide substantial
clinical evidence to support physicians in making appropriate decisions in
patient care and cannabis is a real alternative. Our clinical research follows
all national and international ethical standards, demonstrating our
responsibility to provide all necessary resources to our patients” said Thiago
Callado, CEO and Founder, XLR8 BRAZIL.
The Company looks forward to
announcing further executed deliveries to Brazil in the coming months.
Today, Back Forty – a cannabis brand from Auxly Cannabis Group Inc. (TSX: XLY), introduces Back Forty 40s, a new,
straight-roll offering available now in Ontario at OSC.ca and at cannabis
retail stores across the province. 40s are 0.35g single-strain, straight
pre-rolls, machine rolled for a consistent, even burn with enhanced airflow and
big flavour. Back Forty 40s launch with two high-potency cultivars – Animal
Mints and Wedding Pie – and are presented in resealable, recyclable packages of
10, optimized for sharing out of the pack and preserving freshness. Back Forty
is introducing 40s with an irreverent marketing campaign using Out-Of-Home
advertising to encourage Canadians to unplug and embrace the outdoors by taking
Mondays off through the summer. Back Forty 40s are the centrepiece of a summer
of new product launches, which also features new dried flower strains and the
brand’s first edible offerings.
“We’re
thrilled to launch Back Forty 40s for Canada’s savvy cannabis consumers,
looking for high-quality products at affordable prices,” said Brad Canario,
Senior Director, Marketing, Auxly. “40s are a truly differentiated offering –
leveraging state-of-the-art automation to deliver a straight pre-roll in
packaging perfect for that last-minute camping trip or long day spent at the
lake. For the launch of Back Forty 40s we wanted to make sure we had something
unique in the market that delivered on the brand promise of recalling the
simple joys found in nature. The Monday Merries is a challenge to all Canadians
to focus on what really matters – getting outside – by including Mondays into
the mix on the weekends throughout the rest of the summer.”
Back
Forty, Canada’s #1 vape brandi, is launching 40s as the Canadian pre-roll
market continues to grow. In 2020, pre-rolls were the second-largest product
category in the Canadian market with 17% share of market. So far in 2021,
pre-rolls have secured a 19.3% market share through June 30, 2021.ii
Back
Forty 40s leverage Auxly genetics – the organically grown, high-potency strains
Animal Mints and Wedding Pie. Animal Mints is a cross between Animal Cookies x SinMint Cookies, reaching
potencies of up to 25%, with a total terpene content of up to 2.3%. Wedding Pie
is the marriage of Wedding Cake x Grape Pie, reaching potencies of up to 26%,
with up to 2.9% total terpene content.
This
high-potency flower is machine rolled into 10 x 0.35g packages using
first-of-its kind, state-of-the-art automation designed for consistency, an
even burn and optimal air-flow and flavour. Each easy-to-share pack of 40s has
a resealable film that locks in the freshness. And in true Back Forty fashion,
40s packaging is 100% recyclable. 40s are available in Ontario now, and will be
coming soon to provinces across Canada.
Back
Forty is launching 40s with an innovative Monday
Merries campaign that flips the script on the negative stigma associated
with Mondays. The campaign suggests that the greatest enjoyment is found by
turning a Monday into a funday, so instead of going to work, Back Forty invites
Canadians to explore their personal back forty, and, in doing so, reclaim the
maligned day. The Monday Merries
campaign includes social, digital and Out-Of-Home, with wild posting
advertising soon to be live in major urban centres across Canada including
Toronto, Vancouver, Calgary and Edmonton.
Back
Forty 40s are only one of Back Forty’s numerous product launches this summer,
including new dried flower strains and the brand’s first edibles, S’mores
flavoured chocolates and Sour Cherry and Sour Grape soft chews. These new
products will join Back Forty’s already-popular lineup of vapes and flower,
with more detail to follow in coming weeks.
The
Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF), a leading manufacturer of
cannabis products, announced that it continues to prepare for
international industry growth with upgrades to its leading-edge research and
ISO/IEC 17025:2017 accredited testing facility, Valens Labs.
Valens Labs' testing capabilities
have been enhanced to now further satisfy various additional international
testing requirements for finished cannabis goods to support existing and future
customers looking to expand their export capabilities. The enhanced validation
methods that Valens Labs now offers are in preparation for changes in certain
international analytics and testing requirements. These testing methods, which
have previously been validated in all five tests required by Health Canada*,
have been increased and are expected to be compliant for international
standards in many emerging markets. Valens Labs is also CALA Certified, which
is an internationally recognized leader in providing the highest-quality
accreditation of laboratories.
Valens' third-party testing services
now allows for the testing of more than 300 pesticides, making it the only
cannabis testing lab in Canada with the capabilities to test this magnitude of
contaminants at commercial capacity. This upgrade was made in anticipation of
attracting more global business as testing standards evolve. The current Health
Canada requirement mandates testing for 96 pesticides, however, testing beyond
national requirements will further help customers achieve supreme sampling
validation to ensure quality and safety. The testing capabilities upgrades will
also continue to allow Valens to test and examine for terpenes, cannabinoid
profiles, and microbials, and additional heavy metals such as zinc, nickel, and
palladium.
"Our vision is to become a hub
for international cannabis distribution and a launching pad for CPG companies
who are ready to enter the market," said Tyler Robson, Chief Executive
Officer, Co-Founder and Chair of The Valens Company. "Valens' fully
validated ISO/IEC 17025:2017 accredited lab, one of the first in the Canadian
cannabis industry, will expand our international export capabilities and
contribute to the adoption of cannabis and cannabis products at an
international level."
Robson continued, "We expect
the regulatory standards for food and natural health products to require
stricter and more demanding testing standards. As a result, Valens is preparing
for the future by enabling worldwide manufacturing, distribution and
exportation capabilities of the very best cannabis products."
These upgraded testing services will
be available for Valens' broad customer base, which include Licensed Producers,
individual producers, medicinal cannabis clients, and the natural wellness
products industry.
Orchid
Ventures, Inc. (CSE: ORCD) (OTC: ORVRF) announced that the Company has launched its
proprietary new technology platform PurGuard, which it believes will have a
significant impact on the usage of vape products by minors. Utilizing several
key technologies and developing a proprietary software platform, the Company
has developed an ecosystem for use in 510 thread cartridges and batteries, POD
based systems, as well as disposable vaporizers.
A consumer that purchases a PurGuard
product, will have to verify their age through a web-based and/or mobile
application that pairs with the device via Bluetooth or USB cable. The device
also has an auto-lock feature that when the registered user of the device is
not near the device, the device can auto-lock, eliminating the possibility of a
minor using the device. This technological advancement is believed by the
Company to be perhaps the biggest advancement in vaporizer safety technology in
over a decade.
"The PurGuard Platform is a
major advancement in consumer safety and protection. It has been our mission
from day one, to create the safest electronic cannabis delivery systems in the
world, and with this advancement, we believe we have achieved another milestone
in this mission. Being a software developer for over 20 years, coming up with
software applications and taking them to market has been something I've
personally excelled at for decades," said Corey Mangold, CEO of Orchid
Ventures. "With this experience we have been able to create an ecosystem
of hardware and software to achieve a significant level of protection, which
can reduce and hopefully eliminate the usage of vaporizer products by minors.
For our industry to truly succeed, we have to keep consumer safety at the forefront.
We began this with emissions testing our products ensuring there were no
harmful materials being inhaled, and now we have taken this level of safety and
protection one significant step further. We believe that PurGuard will become
an industry standard and we look forward to working with regulators to ensure
that consumer safety is first and foremost."
With PurGuard products, a customer
(brand) has the ability to "program" their cartridge, PODs or
disposables with information from the lab reports such as brand, logo, strain
name, potency, manufacture date and more. This allows users to know exactly
what they are consuming when switching from cartridge to cartridge.
PurGuard products will be available
to cannabis and CBD companies worldwide by Winter 2021.
These products will also be unveiled
at MJ Biz Con in Las Vegas in mid October 2021.
Investor
ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and that this podcast is not an endorsement to buy products
or services or securities. Investors are reminded all investment involves risk
and possible loss of investment.
Learn
more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear
more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
The Investorideas.com podcasts are also available on
Apple Podcasts , Audible , Spotify,
Tunein, Stitcher, Spreaker.com, iHeartRadio, Google Podcasts and most audio platforms available.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big
Investing Ideas
Investorideas.com
publishes breaking stock news, third
party stock research , guest posts and original
articles and podcasts in leading stock sectors. Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and
IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor
Idea’s original branded content includes podcasts and columns : Crypto Corner , Play
by Play sports and stock news , Investor Ideas Potcasts
Cannabis News and Stocks on the Move podcast ,
Cleantech
and Climate Change , Exploring
Mining , Betting
on Gaming Stocks Podcast and the AI
Eye Podcast.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investing involves risk and possible losses.
This site is currently compensated for news publication and distribution,
social media and marketing, content creation and more. Disclosure is posted for
each compensated news release, content published /created if required but
otherwise the news was not compensated for and was published for the sole
interest of our readers and followers. Contact management and IR of each
company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our
other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country.
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where
permissible by law. Our site does not possess, distribute, or sell cannabis
products.
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Download our Mobile App for
iPhone and Android
Join our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800 665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
No comments:
Post a Comment